In a bid to allay conflict-of-interest concerns, Korean manufacturing giant Samsung Biologics is decoupling from its ...

Kaddis said insurers are locked in a cat-and-mouse game with drugmakers as the insurance sector invests in biosimilars and ...

By Alimat Aliyeva Samsung Biologics Co., the biotech arm of South Korea's Samsung Group, announced Thursday that it pla ...

Orionis Biosciences Inc. is sticking with Genentech Inc. in a second deal to discover small-molecule monovalent glue therapies for treating cancer. Privately held Orionis is getting $105 million up ...

The lyophilized injectable market is poised for growth due to increasing demand for biologics and specialty drugs, R&D activities, and global collabo ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

The global autoimmune disease therapeutics market is poised for substantial growth over the next decade, with industr ...

India is expected to require an additional 45–50 million sq. ft. of real estate and 40–45 terawatt-hours of incremental power by 2030 to meet the accelerating demand for Artificial Intelligence (AI) ...

Alvotech and its U.S. commercial partner Teva Pharmaceutical announced the launch of SELARSDI™ (ustekinumab-aekn) biosimilar to Stelara®, in the U.S. SELARSDI has been granted interchangeability to ...

Over the next 10– 15 years, the biosimilars industry is expected to explode as the patents on branded biologics begin to expire. Analysts agree that biosimilar market size will be fairly ...

Prestige International Pictures, a film sales, financing and production company, will be launching at the Marché du Film during the Cannes Film Festival. The company will be headed by sales ...

The Indian government is refining biosimilar drug regulations, aligning with global standards to ensure stringent quality in research and manufacturing. These revised 'Guidelines on Similar Biologics' ...